The FDA's Marty Makary fast-tracked research for three companies to make psychedelic treatments for mental illness.

Protein is one of the most important macronutrients during pregnancy. It plays a critical role in building and repairing ...

Ziftomenib was approved by the U.S. Food and Drug Administration (FDA) in November 2025 for the treatment of adult patients with R/R NPM1 -m AML who have no satisfactory alternative treatment options, ...